1. Home
  2. AXR vs KALA Comparison

AXR vs KALA Comparison

Compare AXR & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMREP Corporation

AXR

AMREP Corporation

HOLD

Current Price

$28.24

Market Cap

144.1M

Sector

Real Estate

ML Signal

HOLD

Logo KALA BIO Inc.

KALA

KALA BIO Inc.

HOLD

Current Price

$0.11

Market Cap

172.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXR
KALA
Founded
1961
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
144.1M
172.0M
IPO Year
2010
2017

Fundamental Metrics

Financial Performance
Metric
AXR
KALA
Price
$28.24
$0.11
Analyst Decision
Strong Buy
Buy
Analyst Count
1
3
Target Price
$30.00
$31.50
AVG Volume (30 Days)
9.2K
3.1M
Earning Date
03-12-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
89.60
67.39
EPS
1.68
N/A
Revenue
$12,831,000.00
N/A
Revenue This Year
$10.12
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$16.64
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.61
$0.10
52 Week High
$29.00
$20.58

Technical Indicators

Market Signals
Indicator
AXR
KALA
Relative Strength Index (RSI) 54.71 25.11
Support Level $20.02 N/A
Resistance Level $28.57 $0.24
Average True Range (ATR) 0.95 0.02
MACD -0.06 -0.00
Stochastic Oscillator 68.53 3.34

Price Performance

Historical Comparison
AXR
KALA

About AXR AMREP Corporation

Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Share on Social Networks: